Crosswinds Holdings Inc. Stock Other OTC
Equities
CRSWF
CA2276962008
Biotechnology & Medical Research
Financials (USD)
Sales 2021 | - | Sales 2022 | - | Capitalization | 27.36M |
---|---|---|---|---|---|
Net income 2021 | -4M | Net income 2022 | -2M | EV / Sales 2021 | - |
Net cash position 2021 | 2.23 | Net cash position 2022 | 0.02 | EV / Sales 2022 | - |
P/E ratio 2021 |
-17.8
x | P/E ratio 2022 |
-9.17
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.21% |
1st Jan change | Capi. | |
---|---|---|
-0.02% | 42.11B | |
+46.17% | 40.08B | |
+5.04% | 40B | |
-11.32% | 26.87B | |
+5.25% | 24.58B | |
-23.83% | 18.44B | |
-1.62% | 11.94B | |
+22.75% | 11.66B | |
+6.44% | 11.01B |